Position in FATE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$124,794
-$33,975 QoQ
Shares Held
46,220
-65.1% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. FATE ranks #266 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in FATE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $124,794 | 46,220 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $158,769 | 132,308 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $143,825 | 146,761 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $194,148 | 154,086 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $174,560 | 155,858 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $118,695 | 150,248 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $262,633 | 159,172 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $549,493 | 156,998 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $524,803 | 160,001 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,058,251 | 144,176 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $524,852 | 140,335 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $297,525 | 140,342 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $660,250 | 138,708 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $664,329 | 116,549 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,149,664 | 113,941 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,473,010 | 110,353 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,512,146 | 101,378 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,465,340 | 89,382 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $5,185,390 | 88,624 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $5,433,458 | 91,673 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,773,259 | 89,564 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $7,381,501 | 89,527 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $8,662,446 | 95,265 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $3,573,078 | 89,394 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,530,087 | 102,888 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,954,035 | 87,980 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||